Latest Pravachol news
Pravastatin Does Not Improve Survival in Small-Cell Lung Cancer
posted March 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with small-cell lung cancer, addition of pravastatin to standard chemotherapy does not improve survival, according to a study published online Feb. 27 in the Journal of Clinical Oncology.
Editor's Recommendations
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Lung Transplant Can Prolong Survival in Stage IV NSCLC 
KRAS ctDNA Linked to Worse Overall Survival in Localized Pancreatic Cancer 
Risk-Based Strategies Superior to USPSTF Criteria for Lung Cancer Screening Related Articles
Cancer-Attributable Costs High for Seniors, Vary With Cancer Phase, Type, Race .jpg)
Hispanic Patients Face Delays in Frontotemporal Dementia Diagnosis 
Eosinophilic Esophagitis Prevalence May Be Higher Than Thought in Pediatric Patients With Asthma 
Female Emergency Medicine Physicians Order More Tests, Admit More Patients Monthly Specialist Briefings
Stay Connected
